Results 41 to 50 of about 9,590,099 (402)

The Pecularities of Correlation Between Insulin Resistance, Carbohydrate and Lipid Metabolism Indices in Patients with Graves'disease [PDF]

open access: yes, 2017
Aim. The number of patients with endocrine disorders in the world, in particular, Graves' disease is continuously increasing. Recent studies have determined the fact of insulin resistance in thyroid disorders.
Kikhtyak, O. (Olesya)   +2 more
core   +2 more sources

Mediastinal neoplasms in patients with Graves disease: a possible link between sustained hyperthyroidism and thymic neoplasia? [PDF]

open access: yes, 2012
Background Anterior mediastinal masses are a rare but well documented finding in Graves disease. The vast majority of these lesions represents benign thymic hypertrophy and regress after treatment of the hyperthyroidism.
Boyd, Jonathan D, Juskevicius, Ridas
core   +2 more sources

Advances in Graves' Disease [PDF]

open access: yesJournal of Thyroid Research, 2012
“From the very commencement the student should set out to witness the progress and effects of sickness and ought to persevere in the daily observation of disease during the whole period of his studies.” It was Dr. Robert J. Graves who used to pronounce this statement at the inauguration of his yearly university lectures in Dublin.
Lakdasa Premawardhana   +3 more
openaire   +3 more sources

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy

open access: yesThyroid Research, 2019
Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska   +2 more
doaj   +1 more source

Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease [PDF]

open access: yesEndocrinology and Metabolism, 2022
Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate.
Min Joo Kim   +6 more
doaj   +1 more source

Evaluation of vitamin D status and its impact on thyroid related parameters in new onset Graves' disease- A cross-sectional observational study

open access: yesIndian Journal of Endocrinology and Metabolism, 2019
Aims and Objective: We aimed to compare serum vitamin D level in new onset Graves' disease versus age and sex matched controls. Furthermore, we assessed the correlation of vitamin D with hormonal parameters and antibody titers in Graves' disease ...
Swayamsidha Mangaraj   +5 more
doaj   +1 more source

Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review [PDF]

open access: yesEndocrinology and Metabolism, 2022
Background Immunoglobulin G4 (IgG4)-related disease is an entity that can involve the thyroid gland. The spectrum of IgG4-related thyroid disease (IgG4-RTD) includes Hashimoto thyroiditis (HT) and its fibrotic variant, Riedel thyroiditis, as well as ...
Meihua Jin   +7 more
doaj   +1 more source

Graves's Disease [PDF]

open access: yesThe Boston Medical and Surgical Journal, 1880
n ...
openaire   +3 more sources

Oxidative Stress in Graves Disease and Graves Orbitopathy

open access: yesEuropean Thyroid Journal, 2020
Oxidative stress is involved in the pathogenesis of Graves hyperthyroidism (GH) and Graves orbitopathy (GO) and an antioxidant approach has been proposed for both.
G. Lanzolla, C. Marcocci, M. Marinò
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy